First-line Systemic Therapies for Advanced Hepatocellular Carcinoma: A Systematic Review and Patient-Level Network Meta-Analysis
10.1159/000526639
Saved in:
Main Authors: | Fong K.Y., Zhao J.J., Sultana R., Lee J.J.X., Lee S.Y., Chan S.L., Yau T., Tai D.W.M., Sundar R., Too C.W. |
---|---|
Other Authors: | MEDICINE |
Format: | Article |
Published: |
S. Karger AG
2022
|
Subjects: | |
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/233421 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
DESIGNING ANTI-PDL1 ANTIBODY CONJUGATED POLYMERIC COACERVATES AS A NOVEL “NANO-IMMUNOTHERAPY” AGAINST HEPATOCELLULAR CARCINOMA
by: CHERYLETTE ANNE ALEXANDER
Published: (2023) -
Development of a new patient-derived xenograft humanised mouse model to study human-specific tumour microenvironment and immunotherapy
by: Zhao Y., et al.
Published: (2019) -
Circulating markers for prognosis of hepatocellular carcinoma
by: Wong, K.-F., et al.
Published: (2014) -
Value of alpha-foetoprotein for screening of recurrence in hepatocellular carcinoma post resection
by: Chang, S.K.Y., et al.
Published: (2014) -
Global epidemiology and genetics of hepatocellular carcinoma
by: Toh, Ming Ren, et al.
Published: (2023)